## **Trustees’ Annual Report** 

## **for the year 1 January 2024 to 31 December 2024** 

## **Charity name:    BRITISH CONGENITAL CARDIAC ASSOCIATION** 

## **Charity registration number:   1171543** 

## **Objectives and Activities** 

|||
|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|**The advancement of health and education in all aspects**<br>**of congenital cardiac diseases in particular by:**|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|•<br>**Promoting the study and care of the foetus and**<br>**child with heart diseases and the adult with**<br>**congenital heart disease in the United Kingdom**<br>**and Republic of Ireland,**<br>•<br>**Promoting and distributing study data pertaining**<br>**to these problems and their prevention,**<br>•<br>**Promoting research in congenital cardiology and**<br>**to publish the useful results of such research,**<br>**and**<br>•<br>**The improvement of knowledge of professionals,**<br>**the public and the patients and their families**<br>**through scientific and educational meetings.**|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|**In setting the objectives of the Association and planning**<br>**its future activities, the trustees have given careful**<br>**consideration to the Charity Commission’s general**<br>**guidance on public benefit. In particular, the trustees**<br>**consider how planned activities will contribute to the**<br>**aims and objectives that have been set.**|





## **Achievements and Performance** 

|||
|---|---|
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|During the year ended 31 December 2024, the Association<br>received income of £26,502 and made payments of<br>£34,317.<br>Income received included members' subscription fees of<br>£11,875, sponsorship income of £1,500, BCCA conference<br>income of £12,111 and bank interest of £1,017.<br>Payments included £31,208 to the British Cardiovascular<br>Society for the 2023 and 2024 administrative fees/service<br>level agreement. The Association also continued to provide<br>support in the study, research and understanding of<br>congenital heart diseases.<br>The 2024 Annual Meeting was held in person in Dublin over<br>2 days in November 2024. 312 delegates and 411 including<br>speakers were in attendance for this successful meeting.|



## **Financial Review** 

|Review of the charity’s<br>financial position at the end<br>of the period|At 31 December 2024, the charity had cash funds of<br>£71,354. It also had liabilities of £1,800, being accrued<br>independent examination fees covering the 2023 and 2024<br>accounts.<br>The trustees believe that reserves are at a sufficient level<br>to provide the funds to fulfil the objectives of the charity; in<br>particular, monetary support is offered for applications for<br>setting up Registries, research projects and the provision<br>of patient information through web hosting and printed<br>materials. Discussions have also been held regarding the<br>possibility of the Association running its own courses and<br>study days, which would require significant investment.|
|---|---|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|See above|
|Amount of reserves held|See above|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|There are no going concern issues of which the trustees<br>are aware. Assets and liabilities are at a level which<br>enable us to continue to pursue our prime objectives and<br>activities.|





**Structure, Governance and Management** 

|**Structure, Governance**|**and Management**|
|---|---|
|Description of charity’s<br>trusts:||
|Type of governing document|**CONSTITUTION**|
|How is the charity<br>constituted?|**CHARITABLE INCORPORATED ORGANISATION**<br>**(CE009062)**|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|**ELECTED BY MEMBERS IN COUNCIL ELECTIONS**|



## **Reference and Administrative details** 

|Charity name|**BRITISH CONGENITAL CARDIAC ASSOCIATION**|
|---|---|
|Other name the charity uses||
|Registered charity number|**1171543**|
|Charity’s principal address|**9 FITZROY SQUARE**<br>**LONDON**<br>**W1T 5HW**|



## **Names of the charity trustees who manage the charity** 

|1<br>2|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or**<br>**body) entitled to**<br>**appoint trustee (if**<br>**any)**|
|---|---|---|---|---|
||Mr JOHANN<br>ANDREAS<br>HOSCHTITZKY|PRESIDENT|October 2023-October<br>2025|BCCA Members|
||MRS CAROLINE<br>BETHAN WILSON|HON SECRETARY|October 2023 – October<br>2025 – re-elected for a<br>2nd-term October 2025<br>until October 2027|BCCA Members|



## **Funds held as custodian trustees on behalf of others** 

|Description of the assets held in this capacity|N/A|
|---|---|
|Name and objects of the charity on whose<br>behalf the assets are held and how this falls<br>within the custodian charity’s objects|N/A|
|Details of arrangements for safe custody and<br>segregation of such assets from the charity’s<br>own assets|N/A|





## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

|**Signature(s)**||||
|---|---|---|---|
|**Full name(s)**||**MR JOHANN ANDREAS**|**MRS CAROLINE BETHAN WILSON**|
|||**HOSCHTITZKY**||
|**Position**<br>**Date**|**PRESIDENT**<br>31 October 2025<br>~~a~~<br>~~|~~||**HON SECRETARY**|





|**British Congenital Cardiac Association**||**1171543**|||
|---|---|---|---|---|
|**Receipts and payments accounts**||||**CC16a**|
|**To**<br>**For the period**<br>**from**<br>01/01/2024||31/12/2024|||
|**Section A Receipts and payments**|||||
|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Endowment**<br>**funds**||**Total funds**||**Last year**|
|**to the nearest      £**<br>**to the nearest £**<br>**to the nearest £**||**to the nearest £**||**to the nearest £**|
|**A1 Receipts**|||||
|Members' subscriptions<br>**11,875**<br> **-**<br> **-**<br>**11,875**<br>**12,110**<br>Interest received<br>**1,017**<br> **-**<br> **-**<br>**1,017**<br> **-**<br>Grant from Children's Heart Disease<br>Trust for sponsorshipscheme<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Sponsorshipfor ACHD TrainingDay<br>**1,500**<br> **-**<br> **-**<br>**1,500**<br>**2,900**<br>BCCA Conference<br>**12,111**<br> **-**<br> **-**<br>**12,111**<br> **-**<br> **-**<br> **-**<br> **-**<br> **-**<br> **-**<br> **-**<br> **-**<br> **-**<br> **-**<br> **-**<br> **-**<br> **-**<br> **-**<br> **-**<br> **-**<br>**Sub total**(Gross income for<br>AR)<br>**26,502**<br>**-**<br>**-**<br>**26,502**<br>**15,010**<br>~~=== ===~~|||||
|**A2 Asset and investment sales,**<br>**(see table).**<br>**-**<br>**-**<br>**-**<br> **-**<br> **-**<br> **-**<br>**Sub total**<br>**-**<br>**-**<br>**-**<br>**Total receipts**<br>**26,502**<br>**-**<br>**-**<br>~~SS~~||**-**<br> **-**<br>**-**<br>**26,502**||**-**<br> **-**<br>**-**<br>**15,010**|
|**A3 Payments**<br>Expenditure relating to sponsorship<br>scheme<br>**-**<br>**-**<br>**-**<br>**5,811**<br>Funding research<br>**2,710**<br>**-**<br>**-**<br>**2,710**<br>**2,975**<br>Independent examinationcosts<br>**-**<br>**-**<br> **-**<br>**1,686**<br>British Cardiovascular Society<br>**31,208**<br>**-**<br>**-**<br>**31,208**<br>**2,730**<br>Travel and refreshments - Council<br>meetings<br>**399**<br>**-**<br>**-**<br>**399**<br>**370**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Sub total**<br>**34,317**<br>**-**<br>**-**<br>**34,317**<br>**13,572**<br>~~meee~~|||||
|**A4 Asset and investment**<br>**purchases, (see table)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Sub total**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Total payments**<br>**34,317**<br>**-**<br>**-**<br>**34,317**<br>**13,572**<br>~~—saeaSaSs=~~|||||
|**Net receipts/(payments)**<br>**-                 7,815**<br>**-**<br>**-**<br>**A5 Transfers between funds**<br>**-**<br>**-**<br>**-**<br>**A6 Cash funds last year end**<br>**79,169**<br>**-**<br>**-**<br>**Cash funds this year end**<br>**71,354**<br>**-**<br>**-**<br>~~SSSS~~||**-7,815**<br>**-**<br>**79,169**<br>**71,354**||**1,438**<br>**-**<br>**77,731**<br>**79,169**|



1 



## **Section B Statement of assets and liabilities at the end of the period** 

||||**Unrestricted**<br>**Restricted**||**Endowment**|
|---|---|---|---|---|---|
|**Categories**|**Details**||**funds**<br>**funds**||**funds**|
||||**to nearest £**<br>**to nearest £**||**to nearest £**|
|**B1 Cash funds**|**71,354**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**71,354**<br>**-**<br>**-**<br>Cash at Bank<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>~~===>~~|||||
||account(s))||OK<br>OK||OK|
||||**Unrestricted**<br>**Restricted**||**Endowment**|
||||**funds**<br>**funds**||**funds**|
||**Details**||**to nearest £**<br>**to nearest £**||**to nearest £**|
|**B2 Other monetary assets**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>~~—===~~|||||
|**B3 Investment assets**|**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**Current value**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Details**<br>~~ee~~|||||
|**B4 Assets retained for the**<br>**charity’s own use**|**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**Current value**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Details**<br>~~mee~~|||||
||||**Unrestricted**<br>**Restricted**||**Endowment**|
||||**funds**<br>**funds**||**funds**|
||**Details**||**to nearest £**|||
|Signed by one or two trustees on<br>behalf of all the trustees<br>**B5 Liabilities**|**1,800**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Date of<br>approval<br>**12/07/2025**<br>Print Name<br>**Mr J Andreas Hoschtitzky**<br>Signature<br>Accruals re independent examination fees<br>for 2023 and 2024 (paid or payable in 2025)<br>2<br>~~——~~|||||



